Claritas Pharmaceuticals Inc
Save
6.65M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Claritas Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. The company was formerly known as Kalytera Therapeutics, Inc. and changed its name to Claritas Pharmaceuticals, Inc. in April 2021. The company was founded in 2014 and is headquartered in San Rafael, California.

Similar securities

Based on sector and market capitalization

Report issue